κ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Timothy W WhitfieldGeorge F Koob

Abstract

Given that the κ opioid receptor (KOR) system has been implicated in psychostimulant abuse, we evaluated whether the selective KOR antagonist norbinaltorphimine dihydrochloride (nor-BNI) would attenuate the escalation of methamphetamine (METH) intake in an extended-access self-administration model. Systemic nor-BNI decreased the escalation of intake of long-access (LgA) but not short-access (ShA) self-administration. nor-BNI also decreased elevated progressive-ratio (PR) breakpoints in rats in the LgA condition and continued to decrease intake after 17 d of abstinence, demonstrating that the effects of a nor-BNI injection are long lasting. Rats with an ShA history showed an increase in prodynorphin immunoreactivity in both the nucleus accumbens (NAc) core and shell, but LgA animals showed a selective increase in the NAc shell. Other cohorts of rats received nor-BNI directly into the NAc shell or core and entered into ShA or LgA. nor-BNI infusion in the NAc shell, but not NAc core, attenuated escalation of intake and PR responding for METH in LgA rats. These data indicate that the development and/or expression of compulsive-like responding for METH under LgA conditions depends on activation of the KOR system in the NAc shell and...Continue Reading

Citations

Oct 31, 2015·Annual Review of Pharmacology and Toxicology·George F Koob, Barbara J Mason
Dec 15, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Charles Chavkin, George F Koob
Dec 26, 2016·Peptides·Richard J Bodnar
Dec 6, 2016·Trends in Pharmacological Sciences·Matthew L Banks, S Stevens Negus
Jun 8, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A D LêYavin Shaham
Oct 21, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alessandra MatzeuRémi Martin-Fardon
Mar 12, 2016·Drug Target Insights·Junichi KitanakaMotohiko Takemura
Apr 27, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Diana MartinezYiyun Huang
Sep 5, 2019·Experimental Dermatology·Yozo Ishiuji
Jan 11, 2020·Nature Reviews. Disease Primers·John StrangSharon L Walsh
Mar 7, 2020·Frontiers in Pharmacology·Angélica Del Pilar EscobarJosé Antonio Fuentealba
Nov 18, 2016·Frontiers in Neuroscience·Shkelzen ShabaniTamara J Phillips
Feb 16, 2021·Frontiers in Behavioral Neuroscience·Genevieve R CurtisJessica R Barson
Nov 5, 2017·Pharmacology, Biochemistry, and Behavior·Matthew M ClasenAnthony L Riley
May 18, 2021·Neurobiology of Stress·Renata C N MarchetteLeandro F Vendruscolo
Aug 8, 2021·International Journal of Molecular Sciences·Jordan D LewickyHoang-Thanh Le
Jun 10, 2020·Cold Spring Harbor Perspectives in Medicine·Louk J M J Vanderschuren, Serge H Ahmed

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.